Rule 10b5-1 Sales PlanRule 10b5-1 Sales Plan • August 16th, 2021 • Acuitas Group Holdings, LLC • Services-misc health & allied services, nec
This Rule 10b5-1 Sales Plan is entered into on August 13, 2021 (this “Sales Plan”) between Acuitas Group Holdings, LLC (“Seller”) and Jefferies LLC (“Broker”), acting as agent for Seller.
Rule 10b5-1 Sales PlanRule 10b5-1 Sales Plan • September 13th, 2023 • Rothberg Jonathan M • Measuring & controlling devices, nec
This Rule 10b5-1 Sales Plan is entered into on September 11, 2023 (this “Sales Plan”) between Dr. Jonathan Rothberg (“Seller”), acting on his own behalf and on behalf of each of: NVR TR, LLC, JNR TR, LLC, JAR TR, LLC, EJR TR, LLC and GBR TR, LLC (each a “Selling Entity”), and Jefferies LLC (“Broker”), acting as agent for Seller.
RULE 10B5-1 SALES PLANRule 10b5-1 Sales Plan • March 26th, 2014 • Lerner Darrell • Services-business services, nec • New York
THIS RULE 10B5-1 SALES PLAN (this “Plan”) is made, entered into, and effective as of September 13, 2013 (the “Effective Date”) by and between Merriman Capital, Inc. (“Broker”) and Darrell Lerner (“Seller”).
Rule 10b5-1 Sales PlanRule 10b5-1 Sales Plan • October 4th, 2022 • Goodman Anthony Brian • Services-prepackaged software • New York
This Rule 10b5-1 Sales Plan (“Plan”) adopted on April 1, 2022 (the “Adoption Date”), is entered into between Anthony Brian Goodman (“Seller”) and Oppenheimer & Co. Inc., (“Oppenheimer”) for the purpose of establishing a sales plan that complies with the requirements of paragraph (c)(1) of Rule 10b5-1 (“Rule 10b5-1”) under the Securities Exchange Act of 1934 (the “Exchange Act”), with respect to Seller’s sale of the shares of common stock (the “Shares”) of Golden Matrix Group, Inc. (“Issuer”), including (if applicable) Shares underlying vested and currently exercisable stock options that are identified in Exhibit A hereto (the “Stock Options”). Unless otherwise indicated, all section references pertain to sections within this Plan.
RecitalsRule 10b5-1 Sales Plan • December 12th, 2006 • DFW Capital Partners Lp • Services-skilled nursing care facilities
Rule 10b5-1 Sales PlanRule 10b5-1 Sales Plan • October 4th, 2022 • Feng Weiting • Services-prepackaged software • New York
This Rule 10b5-1 Sales Plan (“Plan”) adopted on September 12, 2022 (the “Adoption Date”), is entered into between Weiting Feng (“Seller”) and Oppenheimer & Co. Inc., (“Oppenheimer”) for the purpose of establishing a sales plan that complies with the requirements of paragraph (c)(1) of Rule 10b5-1 (“Rule 10b5-1”) under the Securities Exchange Act of 1934 (the “Exchange Act”), with respect to Seller’s sale of the shares of common stock (the “Shares”) of Golden Matrix Group, Inc. (“Issuer”), including (if applicable) Shares underlying vested and currently exercisable stock options that are identified in Exhibit A hereto (the “Stock Options”). Unless otherwise indicated, all section references pertain to sections within this Plan.
Exhibit E Rule 10b5-1 Sales PlanRule 10b5-1 Sales Plan • December 11th, 2006 • RFE Investment Partners V, L.P. • Services-skilled nursing care facilities
This Rule 10b5-1 Sales Plan is entered into on December 8, 2006 (This “Plan”) between [RFE INVESTMENT PARTNERS V, L.P.][RFE VI SBIC, L.P.] (“Seller”) and Jefferies & Company, Inc. (“Broker”), acting as agent for Seller.
Rule 10b5-1 Sales PlanRule 10b5-1 Sales Plan • March 22nd, 2021 • Ripple Labs Inc. • Services-business services, nec
This Rule 10b5-1 Sales Plan was entered into on March 10, 2021 (this “Sales Plan”) between Ripple Labs Inc. (“Seller”) and Jefferies LLC (“Broker”), acting as agent for Seller, and is amended and restated on March 19, 2021.
Rule 10b5-1 Sales PlanRule 10b5-1 Sales Plan • March 11th, 2021 • Ripple Labs Inc. • Services-business services, nec
This Rule 10b5-1 Sales Plan is entered into on March 10, 2021 (this “Sales Plan”) between Ripple Labs Inc. (“Seller”) and Jefferies LLC (“Broker”), acting as agent for Seller.
Rule 10b5-1 Sales PlanRule 10b5-1 Sales Plan • November 29th, 2024 • Goodman Anthony Brian • Services-prepackaged software • New York
This Rule 10b5-1 Sales Plan (“Plan”) adopted on November 29, 2024 (the “Adoption Date”), is entered into between Anthony Goodman (“Seller”) and Oppenheimer & Co. Inc., (“Oppenheimer”) for the purpose of establishing a sales plan that complies with the requirements of paragraph (c)(1) of Rule 10b5-1 (“Rule 10b5-1”) under the Securities Exchange Act of 1934 (the “Exchange Act”), with respect to Seller’s sale of the shares of common stock (the “Shares”) of Golden Matrix Group Inc.(“Issuer”), including (if applicable) Shares underlying vested and currently exercisable stock options that are identified in Exhibit A hereto (the “Stock Options”). Unless otherwise indicated, all section references pertain to sections within this Plan.
Rule 10b5-1 Sales PlanRule 10b5-1 Sales Plan • September 13th, 2023 • Rothberg Jonathan M • X-ray apparatus & tubes & related irradiation apparatus
This Rule 10b5-1 Sales Plan is entered into on September 11, 2023 (this “Sales Plan”) between Dr. Jonathan Rothberg (“Seller”), acting on his own behalf and on behalf of each of: NVR TR, LLC, JNR TR, LLC, JAR TR, LLC, EJR TR, LLC and GBR TR, LLC (each a “Selling Entity”), and Jefferies LLC (“Broker”), acting as agent for Seller.
Rule 10b5-1 Sales PlanRule 10b5-1 Sales Plan • April 12th, 2024 • Feng Weiting • Services-prepackaged software • New York
This Rule 10b5-1 Sales Plan (“Plan”) adopted on September 21, 2023 (the “Adoption Date”), is entered into between Weiting Feng (“Seller”) and Oppenheimer & Co. Inc., (“Oppenheimer”) for the purpose of establishing a sales plan that complies with the requirements of paragraph (c)(1) of Rule 10b5-1 (“Rule 10b5-1”) under the Securities Exchange Act of 1934 (the “Exchange Act”), with respect to Seller’s sale of the shares of common stock (the “Shares”) of Golden Matrix Group Inc.(“Issuer”), including (if applicable) Shares underlying vested and currently exercisable stock options that are identified in Exhibit A hereto (the “Stock Options”). Unless otherwise indicated, all section references pertain to sections within this Plan.
RULE 10B5-1 SALES PLANRule 10b5-1 Sales Plan • June 24th, 2011 • Talon Therapeutics, Inc. • Pharmaceutical preparations
This Rule 10b-5-1 Sales Plan, dated June 13, 2011 (this “Sales Plan”) is made by and between UBS Securities, LLC (“Broker”), Deerfield Management Company, L.P., Series C, a Delaware limited partnership (the “Investment Manager”) and the following parties (each a “Stockholder” and together the “Stockholders”): Deerfield Private Design Fund, L.P., a Delaware limited partnership, Deerfield Private Design International, L.P. a British Virgin Islands limited partnership, Deerfield Special Situation Fund, L.P., a Delaware limited partnership, and Deerfield Special Situations Fund International Limited, a British Virgin Islands corporation.
